• Biomerica CEO Zackary S. Irani bought 31,250 common shares at USD 1.6 each in a private placement.
• His direct stake rose to 242,570 shares following the purchase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biomerica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-040443), on August 27, 2026, and is solely responsible for the information contained therein.